{"id":"placebo-granule","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.","oneSentence":"This drug is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:33.192Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07221292","phase":"PHASE3","title":"Pivotal Study of N-acetyl-L-leucine for CACNA1A","status":"NOT_YET_RECRUITING","sponsor":"IntraBio Inc","startDate":"2026-09-01","conditions":"CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2","enrollment":60},{"nctId":"NCT07325903","phase":"EARLY_PHASE1","title":"Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2026-04-01","conditions":"Puberty, Precocious","enrollment":100},{"nctId":"NCT07029178","phase":"PHASE2","title":"Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis","status":"RECRUITING","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2025-11-24","conditions":"Radiation Induced Oral Mucositis, Radiodermatitis","enrollment":160},{"nctId":"NCT07456813","phase":"NA","title":"Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period","status":"NOT_YET_RECRUITING","sponsor":"Cuiling Feng","startDate":"2026-03-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":126},{"nctId":"NCT07454421","phase":"PHASE1, PHASE2","title":"Racecadotril for Organ Injury in Sepsis Patients","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-04-01","conditions":"Sepsis","enrollment":44},{"nctId":"NCT07101640","phase":"PHASE1, PHASE2","title":"PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-02-23","conditions":"Bronchopulmonary Dysplasia (BPD), Premature Births, Critical Illness","enrollment":28},{"nctId":"NCT02932150","phase":"PHASE2","title":"Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2016-11","conditions":"Chronic Hepatitis B","enrollment":150},{"nctId":"NCT05175105","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-06","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":30},{"nctId":"NCT05144256","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-08","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":49},{"nctId":"NCT06068478","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-11-07","conditions":"Gouty Arthritis","enrollment":472},{"nctId":"NCT06686355","phase":"PHASE2","title":"The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula","status":"RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2024-11-20","conditions":"Sepsis Induced Myocardial Dysfunction","enrollment":80},{"nctId":"NCT04589650","phase":"PHASE2","title":"Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-04-19","conditions":"PIK3CA-related Overgrowth Spectrum (PROS)","enrollment":206},{"nctId":"NCT07390565","phase":"NA","title":"YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"LI FENG","startDate":"2026-02-17","conditions":"Extensive-stage Small Cell Lung Cancer (SCLC)","enrollment":308},{"nctId":"NCT06523400","phase":"PHASE3","title":"The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2","status":"RECRUITING","sponsor":"Lupin Ltd.","startDate":"2025-02-13","conditions":"Myotonic Dystrophy","enrollment":176},{"nctId":"NCT07029867","phase":"NA","title":"Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Ying Gao","startDate":"2026-03-15","conditions":"Relapse Remitting Multiple Sclerosis","enrollment":152},{"nctId":"NCT05230784","phase":"NA","title":"The PURI-HF (Air Purifiers on Heart Failure) Trial","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2024-03-06","conditions":"Heart Failure","enrollment":255},{"nctId":"NCT06674252","phase":"NA","title":"A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery","status":"RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2025-06-13","conditions":"Lung Cancers","enrollment":174},{"nctId":"NCT07360002","phase":"NA","title":"The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Keda Lu","startDate":"2026-01","conditions":"IgA Nephropathy (IgAN)","enrollment":102},{"nctId":"NCT06696261","phase":"PHASE3","title":"A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-02-27","conditions":"Postprandial Distress Syndrome","enrollment":342},{"nctId":"NCT07347340","phase":"PHASE3","title":"Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Diminished Ovarian Reserve (DOR)","enrollment":348},{"nctId":"NCT07334912","phase":"PHASE2","title":"AEF0217 in Participants With Down Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Aelis Farma","startDate":"2025-12-20","conditions":"Down Syndrome (Trisomy 21)","enrollment":188},{"nctId":"NCT04147871","phase":"PHASE2, PHASE3","title":"Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children","status":"WITHDRAWN","sponsor":"Advicenne Pharma","startDate":"2024-03-01","conditions":"Cystinuria","enrollment":""},{"nctId":"NCT07321535","phase":"NA","title":"Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"Wangjing Hospital, China Academy of Chinese Medical Sciences","startDate":"2026-01-15","conditions":"Sarcopenia","enrollment":106},{"nctId":"NCT06534723","phase":"PHASE3","title":"Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)","status":"RECRUITING","sponsor":"Sichuan Jishengtang Pharmaceutical Co., Ltd.","startDate":"2024-08-20","conditions":"Alzheimer's Dementia","enrollment":570},{"nctId":"NCT07306494","phase":"PHASE4","title":"Compound Ciwujia Granules in the Treatment of Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Hui Zhu","startDate":"2026-01","conditions":"Insomnia Disorder","enrollment":1200},{"nctId":"NCT07296614","phase":"PHASE3","title":"Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-12-25","conditions":"Diminished Ovarian Reserve (DOR), Infertility","enrollment":320},{"nctId":"NCT04810689","phase":"PHASE2","title":"Pilot Trial of XFBD, a TCM, in Persons With COVID-19","status":"TERMINATED","sponsor":"Darcy Spicer","startDate":"2021-03-01","conditions":"Covid19","enrollment":10},{"nctId":"NCT06857487","phase":"PHASE1, PHASE2","title":"Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2025-06-13","conditions":"Acute Ischemic Stroke","enrollment":72},{"nctId":"NCT07114536","phase":"NA","title":"Evaluation of the Efficacy of Calcium a -Ketoglutarate(AKG-Ca) in Improving Human Aging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shenzhen Hygieia Biotech Co., Ltd","startDate":"2025-08-20","conditions":"Aging","enrollment":30},{"nctId":"NCT04658186","phase":"PHASE2","title":"A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2020-12-30","conditions":"Early-stage Parkinson's Disease","enrollment":496},{"nctId":"NCT06562114","phase":"PHASE1","title":"A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment","status":"COMPLETED","sponsor":"Merry Life Biomedical Co., Ltd.","startDate":"2024-07-11","conditions":"Healthy","enrollment":72},{"nctId":"NCT07207941","phase":"NA","title":"Effect of Probiotics on Quality of Life, Activities of Daily Living and Anxiety in Post Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"National University of Malaysia","startDate":"2025-09-30","conditions":"Stroke","enrollment":110},{"nctId":"NCT07206745","phase":"NA","title":"A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections","status":"NOT_YET_RECRUITING","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2025-10-01","conditions":"Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection","enrollment":152},{"nctId":"NCT05775848","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)","status":"ACTIVE_NOT_RECRUITING","sponsor":"ML Bio Solutions, Inc.","startDate":"2023-05-31","conditions":"Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)","enrollment":81},{"nctId":"NCT07050563","phase":"NA","title":"Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Municipal Hospital of Traditional Chinese Medicine","startDate":"2025-10-06","conditions":"Cancer, Cancer Symptom Clusters","enrollment":316},{"nctId":"NCT06813274","phase":"PHASE2","title":"Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling","status":"NOT_YET_RECRUITING","sponsor":"Hejiang Ye","startDate":"2026-01-01","conditions":"Diabetes Mellitus, Diabetic Retinopathy, Cognitive Impairment","enrollment":160},{"nctId":"NCT06507813","phase":"PHASE3","title":"Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza","status":"COMPLETED","sponsor":"Jiaxing AnDiCon Biotech Co.,Ltd","startDate":"2024-08-19","conditions":"Influenza Type A, Influenza Type B","enrollment":190},{"nctId":"NCT07189169","phase":"PHASE3","title":"QA108 Phase III Study in Subjects With Intermediate AMD","status":"RECRUITING","sponsor":"Smilebiotek Zhuhai Limited","startDate":"2025-07-08","conditions":"Intermediate Age-Related Macular Degeneration","enrollment":400},{"nctId":"NCT04255277","phase":"PHASE1","title":"To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2020-01-31","conditions":"Healthy Subjects","enrollment":97},{"nctId":"NCT07178184","phase":"PHASE2","title":"Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-11-01","conditions":"Pneumoconiosis","enrollment":80},{"nctId":"NCT07085143","phase":"PHASE4","title":"Clinical Study of Compound Ciwujia Granules in the Treatment of Depression","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-10-01","conditions":"Depression - Major Depressive Disorder, Depression Disorders","enrollment":60},{"nctId":"NCT07163702","phase":"PHASE2","title":"Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2025-10-01","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT07159412","phase":"NA","title":"Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-08-31","conditions":"Helicobacter Pylori Infection, Metabolic-associated Steatohepatitis, High-dose Dual Therapy","enrollment":286},{"nctId":"NCT06892093","phase":"NA","title":"Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-07","conditions":"HER2-positive Breast Cancer, Diarrhea Caused by Drug, Neratinib","enrollment":308},{"nctId":"NCT04815083","phase":"PHASE3","title":"Fluorescence Imaging of Carcinoma During Breast Conserving Surgery","status":"TERMINATED","sponsor":"SBI ALApharma Canada, Inc.","startDate":"2021-04-27","conditions":"Breast Neoplasm Female, Breast Cancer","enrollment":57},{"nctId":"NCT06650644","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms.","status":"COMPLETED","sponsor":"Miae Oh","startDate":"2024-10-10","conditions":"Autism Spectrum Disorder","enrollment":48},{"nctId":"NCT06514339","phase":"EARLY_PHASE1","title":"Evidence-based Evaluation and Mechanism of Shenhuang Granules in the Treatment of Sepsis","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2024-07-01","conditions":"Sepsis","enrollment":410},{"nctId":"NCT07138014","phase":"PHASE2","title":"FHND1002 for ALS Treatment: Phase 2","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","startDate":"2025-10-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":180},{"nctId":"NCT07129499","phase":"NA","title":"Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Famous Medical Technology Co., Ltd.","startDate":"2025-08-15","conditions":"Colorectal Adenoma, High Risk, TCM","enrollment":450},{"nctId":"NCT06483373","phase":"EARLY_PHASE1","title":"A Clinical Study of SPH7854 Granules in Healthy Subjects.","status":"RECRUITING","sponsor":"Shanghai Pharmaceuticals Holding Co., Ltd","startDate":"2024-05-28","conditions":"Inflammatory Bowel Disease","enrollment":111},{"nctId":"NCT07123116","phase":"NA","title":"Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Famous Medical Technology Co., Ltd.","startDate":"2025-08-15","conditions":"Colorectal Adenoma, TCM, Low Risk","enrollment":450},{"nctId":"NCT06361108","phase":"PHASE1","title":"MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP","status":"RECRUITING","sponsor":"Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.","startDate":"2024-05-16","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":24},{"nctId":"NCT06914713","phase":"NA","title":"Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF","status":"NOT_YET_RECRUITING","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2025-08-01","conditions":"Idiopathic Pulmonary Fibrosis(IPF)","enrollment":384},{"nctId":"NCT07100743","phase":"NA","title":"Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National University of Malaysia","startDate":"2023-04-03","conditions":"Epilepsies Refractory","enrollment":78},{"nctId":"NCT06673056","phase":"PHASE3","title":"A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)","status":"ACTIVE_NOT_RECRUITING","sponsor":"IntraBio Inc","startDate":"2025-03-18","conditions":"Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T)","enrollment":60},{"nctId":"NCT06055179","phase":"NA","title":"XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)","status":"RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2024-03-08","conditions":"Xiao Chai Hu Tang, Irinotecan-induced Diarrhea","enrollment":98},{"nctId":"NCT06818487","phase":"NA","title":"Ganyan-1 in Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2025-07-01","conditions":"Dry Eye, TCM","enrollment":219},{"nctId":"NCT05819541","phase":"PHASE2","title":"Treating Exacerbations of Asthma With Oral Montelukast in Children","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-10-20","conditions":"Status Asthmaticus","enrollment":90},{"nctId":"NCT05163288","phase":"PHASE3","title":"A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C","status":"RECRUITING","sponsor":"IntraBio Inc","startDate":"2022-06-30","conditions":"Niemann-Pick Disease, Type C","enrollment":53},{"nctId":"NCT06096259","phase":"PHASE2","title":"Preventing Injured Knees From osteoArthritis: Severity Outcomes","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-05-06","conditions":"Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear","enrollment":512},{"nctId":"NCT06927258","phase":"NA","title":"Application of Changyanning Granule in Endoscopic Resection of Colorectal Polyps","status":"ENROLLING_BY_INVITATION","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-11-01","conditions":"Colorectal Polyps","enrollment":1000},{"nctId":"NCT06925386","phase":"PHASE2","title":"The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2025-05-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT05980520","phase":"NA","title":"Study on the Treatment of Taurine in Children With Autism","status":"COMPLETED","sponsor":"Guizhou Provincial People's Hospital","startDate":"2023-08-18","conditions":"Autism Spectrum Disorder","enrollment":64},{"nctId":"NCT05056194","phase":"PHASE2","title":"Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study","status":"WITHDRAWN","sponsor":"XWPharma","startDate":"2021-11-01","conditions":"Parkinson Disease, Excessive Daytime Somnolence","enrollment":""},{"nctId":"NCT06494683","phase":"NA","title":"Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Jiangxi University of Traditional Chinese Medicine","startDate":"2024-07-25","conditions":"Type 2 Diabetes Mellitus","enrollment":200},{"nctId":"NCT03767855","phase":"PHASE1","title":"A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Cytokinetics","startDate":"2018-12-04","conditions":"Symptomatic Obstructive Hypertrophic Cardiomyopathy, Healthy Subjects","enrollment":114},{"nctId":"NCT06782958","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults","status":"ENROLLING_BY_INVITATION","sponsor":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","startDate":"2024-07-05","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":72},{"nctId":"NCT04035824","phase":"PHASE4","title":"Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study","status":"COMPLETED","sponsor":"Shanghai Institute of Hypertension","startDate":"2019-10-08","conditions":"Hypertension","enrollment":605},{"nctId":"NCT06753890","phase":"PHASE3","title":"Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)","status":"NOT_YET_RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2024-12-30","conditions":"Diarrhea-predominant Irritable Boewl Syndrome","enrollment":520},{"nctId":"NCT06427980","phase":"NA","title":"Efficacy and Safety of Chinese Herbal HuoXue LiShui Formula for Chronic Subdural Hematoma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-02-01","conditions":"Chronic Subdural Hematoma","enrollment":160},{"nctId":"NCT05709249","phase":"PHASE3","title":"Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer","status":"RECRUITING","sponsor":"Jiangsu Famous Medical Technology Co., Ltd.","startDate":"2022-12-01","conditions":"Colon Cancer","enrollment":730},{"nctId":"NCT06747325","phase":"NA","title":"Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2025-01-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":120},{"nctId":"NCT06377761","phase":"NA","title":"Study on Heart Failure with Preserved Ejection Fraction with Qishen Granules","status":"RECRUITING","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2023-05-01","conditions":"Heart Failure with Preserved Ejection Fraction","enrollment":80},{"nctId":"NCT04920149","phase":"PHASE2","title":"Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome","status":"RECRUITING","sponsor":"Ann-Sofie Backman","startDate":"2022-03-21","conditions":"Lynch Syndrome, Colon Cancer, Colon Neoplasm","enrollment":150},{"nctId":"NCT06722950","phase":"PHASE2","title":"Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Shandong New Time Pharmaceutical Co., LTD","startDate":"2024-12","conditions":"Colorectal Adenoma","enrollment":120},{"nctId":"NCT06700408","phase":"PHASE2","title":"RCT for the Chinese Medicine in Treating Hypercholesterolemia","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-01","conditions":"Hypercholesterolemia","enrollment":70},{"nctId":"NCT06697886","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-11-16","conditions":"Common Cold","enrollment":480},{"nctId":"NCT03277170","phase":"PHASE2","title":"Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2025-09-01","conditions":"Asthma; Status, Asthma in Children, Asthma Acute","enrollment":""},{"nctId":"NCT04976023","phase":"PHASE2","title":"The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis","status":"COMPLETED","sponsor":"Prof. Lin Zhixiu","startDate":"2022-04-12","conditions":"Allergic Rhinitis","enrollment":58},{"nctId":"NCT06674148","phase":"PHASE2, PHASE3","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)","status":"RECRUITING","sponsor":"Huilan Zhang","startDate":"2024-10-25","conditions":"Interstitial Lung Disease, Qifangfeixian Granules","enrollment":124},{"nctId":"NCT06455670","phase":"NA","title":"Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD","status":"NOT_YET_RECRUITING","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2024-10-20","conditions":"Acute Exacerbation Of Chronic Obstructive Pulmonary Disease","enrollment":468},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT06608017","phase":"PHASE2, PHASE3","title":"Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-10-01","conditions":"Allergic Rhinitis","enrollment":140},{"nctId":"NCT04170504","phase":"PHASE2, PHASE3","title":"Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-11-14","conditions":"Rheumatoid Arthritis","enrollment":204},{"nctId":"NCT04492787","phase":"PHASE2","title":"Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2020-07-06","conditions":"Irritable Bowel Syndrome with Diarrhea","enrollment":240},{"nctId":"NCT06575478","phase":"PHASE2","title":"Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients","status":"RECRUITING","sponsor":"Beijing Supreme Life Pharmaceutical Technology Co., Ltd.","startDate":"2024-07-31","conditions":"Diabetes Mellitus, Type 2, Diabetes, Type2diabetes","enrollment":72},{"nctId":"NCT06570668","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of CDD-2101 in Health Volunteers","status":"COMPLETED","sponsor":"Centre for Chinese Herbal Medicine Drug Development Limited","startDate":"2024-05-29","conditions":"Constipation - Functional","enrollment":20},{"nctId":"NCT05764200","phase":"NA","title":"Acute Microbial Switch","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2024-01-01","conditions":"Insulin Sensitivity, Glucose Metabolism Disorders (Including Diabetes Mellitus), Hyperinsulinism","enrollment":28},{"nctId":"NCT06525168","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414","status":"RECRUITING","sponsor":"Chendu DIAO Nine Hong Pharmaceutical Factory","startDate":"2024-02-06","conditions":"Ischemic Stroke","enrollment":82},{"nctId":"NCT06511011","phase":"PHASE2","title":"Chinese Medicine in Treating Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-09","conditions":"Insomnia Chronic","enrollment":76},{"nctId":"NCT05562219","phase":"PHASE2","title":"QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"Smilebiotek Zhuhai Limited","startDate":"2022-06-29","conditions":"Intermediate Age-Related Macular Degeneration","enrollment":120},{"nctId":"NCT04861376","phase":"NA","title":"Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia","status":"COMPLETED","sponsor":"Jiangxi University of Traditional Chinese Medicine","startDate":"2021-06-05","conditions":"Dyslipidemias","enrollment":174},{"nctId":"NCT05772871","phase":"PHASE4","title":"The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"Jianhua Zhou","startDate":"2023-04-26","conditions":"Nephrotic Syndrome in Children","enrollment":402},{"nctId":"NCT06147635","phase":"PHASE2","title":"Prophylactic Tributyrin Supplementation in Acute Pancreatitis","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2024-02-12","conditions":"Acute Pancreatitis","enrollment":92},{"nctId":"NCT03201848","phase":"PHASE4","title":"The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qidong Gaitianli Medicines Co., Ltd","startDate":"2017-11-16","conditions":"Immune Thrombocytopenia","enrollment":216},{"nctId":"NCT06358118","phase":"NA","title":"Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders","status":"NOT_YET_RECRUITING","sponsor":"Qing Ni","startDate":"2024-07-06","conditions":"Diabete Mellitus, Aging, Metabolic Disorders","enrollment":240},{"nctId":"NCT02086864","phase":"PHASE2","title":"A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2014-03","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":151},{"nctId":"NCT03299322","phase":"PHASE2","title":"A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2017-10-01","conditions":"Bronchial Asthma","enrollment":240},{"nctId":"NCT06381960","phase":"PHASE2","title":"Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe","status":"RECRUITING","sponsor":"Jianhui Tian","startDate":"2023-03-01","conditions":"Lung Cancer","enrollment":356},{"nctId":"NCT06394128","phase":"PHASE2","title":"Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2024-04-30","conditions":"Cancer-Related Fatigue, Colorectal Cancer","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Radiotherapy"],"phase":"phase_3","status":"active","brandName":"Placebo granule","genericName":"Placebo granule","companyName":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","companyId":"xiyuan-hospital-of-china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo granules are a type of intervention used in clinical studies, including those for Inflammatory Bowel Disease, Stroke, Critically Ill, IgA Nephropathy at High Risk of Developing ESRD, and Covid19. Placebo granules are a small molecule modality, classified as a type of intervention in clinical trials, but their exact mechanism of action is not specified in the provided information.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}